Free tool
Drugs in development
Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations
Drugs in development
3,685
Not FDA-approved
In Phase 3
1,424
Highest phase reached
Matching your filters
3,685
3,685 drugs in development
Names, sponsors and conditions come from the trial records. Click a drug for its trials.
- SYT-510Phase 21 trial
Synendos Therapeutics AG · Generalized Anxiety Disorder
- T1695Phase 21 trial
Laboratoires Thea · Moderate to Severe Vernal Keratoconjunctivitis
- Tacrolimus prolonged releasePhase 21 trial
Astellas · Intestine Transplantation, Kidney Transplantation, Lung Transplantation
- TagmokitugPhase 21 trial
Coherus Oncology, Inc. · Solid Tumor
- TAK-007Phase 21 trial
Takeda · Relapsed or Refractory (r/r) B-cell Non-Hodgkin Lymphoma (NHL)
- TAK-101Phase 21 trial
Takeda · Celiac Disease
- TAK-188Phase 21 trial
Takeda · Advanced or Metastatic Solid Tumors
- TAK-242Phase 21 trial
Yaqrit Ltd · Acute-On-Chronic Liver Failure, Alcoholic Hepatitis, Liver Cirrhosis, Alcoholic
- TAK-341MEDI1341Phase 21 trial
Takeda · Multiple System Atrophy
- TAK-411Hypersialylated Immune Globulin GPhase 21 trial
Takeda · Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
- TAK-505Phase 21 trial
Takeda · Malignant Solid Tumors
- TAR-0520Phase 21 trial
Tarian Pharma · Hand and Foot Syndrome
- TAS0953HM06Phase 21 trial
Taiho Pharmaceutical Co., Ltd. · RET-altered Non Small Cell Lung Cancer, RET-altered Solid Tumors
- TAVO101Phase 21 trial
Tavotek Biotherapeutics · Atopic Dermatitis
- TavoceptLP-300, BNP7787Phase 21 trial
Lantern Pharma Inc. · Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung
- TB-500Phase 21 trial
Hudson Biotech · Atherosclerotic Cardiovascular Diseases, Endothelial Dysfunction
- TB006Phase 21 trial
TrueBinding, Inc. · Parkinson's Disease (PD)
- TB511Phase 21 trial
Twinpig Biolab, Inc. · NSCLC, Prostate Cancer, Colorectal Cancer
- TBI-1501Phase 21 trial
Takara Bio Inc. · Lymphoblastic Leukemia, Acute Adult
- TBO-309Phase 21 trial
ThromBio Pty. Ltd. · Ischemic Stroke, Tandem Occlusion
- TBS-2025trovostobartPhase 21 trial
TuHURA Biosciences, Inc. · Acute Myeloid Leukemia
- TC011Phase 21 trial
TICAROS Co., Ltd. · Relapsed Large B-cell Lymphoma, Refractory Large B-cell Lymphoma, Diffuse Large B-cell Lymphoma (DLBCL)
- TCMCB07Phase 21 trial
Endevica Bio · Cancer Weight Loss
- TCP-25Phase 21 trial
Xinnate AB · Epidermolysis Bullosa (EB), Dystrophic Epidermolysis Bullosa, Junctional Epidermolysis Bullosa
- TD001Phase 21 trial
T.O.A.D. Oncology SA · Metastatic Castration-Resistant Prostatic Cancer
- TenalisibRP6530Phase 21 trial
Rhizen Pharmaceuticals SA · Triple Negative Breast Cancer (TNBC)
- TER-2013Phase 21 trial
Terremoto Biosciences Inc. · Breast Cancer, Endometrial Cancer, Ovarian Cancer
- TERN-601Phase 21 trial
Terns, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) · Overweight or Obesity
- TG4001Phase 21 trial
Transgene · HPV-Related Carcinoma, HPV-Related Cervical Carcinoma, HPV-Related Anal Squamous Cell Carcinoma
- TG4050Phase 21 trial
Transgene · Squamous Cell Carcinoma of Head and Neck
- TGD001Phase 21 trial
TargED Biopharmaceuticals B.V. · Thrombotic Microangiopathies, ITP Immune-Mediated Thrombocytopenia
- TGM-312-SC01Phase 21 trial
Tangram Therapeutics Plc · Healthy Participants, MASH - Metabolic Dysfunction-Associated Steatohepatitis
- TGRX-814Phase 21 trial
Shenzhen TargetRx Co., Ltd. · Hematologic Malignancy, Non Hodgkin Lymphoma, Acute Myeloid Leukemia
- TGX-007Phase 21 trial
Trogenix ltd · Glioblastoma (GBM), High Grade Gliomas, Recurrent Glioblastoma
- TH9619Phase 21 trial
One-carbon Therapeutics AB · Solid Tumor, Colorectal Cancer (CRC), Squamous Cell Carcinoma of Head and Neck
- THDBH120Phase 21 trial
Tonghua Dongbao Pharmaceutical Co.,Ltd · Overweight or Obese
- TILT-123Ad5, 3-E2F-d24-hTNFa-IRES-hIL2Phase 21 trial
TILT Biotherapeutics Ltd. · Platinum-refractory Ovarian Carcinoma, Platinum-resistant Ovarian Cancer, Platinum-Resistant Fallopian Tube Carcinoma
- TISA-818-InjPhase 21 trial
EnliTISA (Shanghai) Pharmaceutical Co., Ltd. · Acute Respiratory Distress Syndrome (ARDS)
- TJ004309Phase 21 trial
TJ Biopharma Co., Ltd. · Advanced Solid Tumor
- TJ102Phase 21 trial
Phrontline Biopharma · Ovarian Cancer
- TJO-087Phase 21 trial
Taejoon Pharmaceutical Co., Ltd. · Dry Eye Syndrome (DES)
- TK216Phase 21 trial
Shanghai Pharmaceuticals Holding Co., Ltd · Sarcoma, Ewing
- TL-895Phase 21 trial
Telios Pharma, Inc. · Myelofibrosis, Primary Myelofibrosis, Post-PV MF
- TL117Phase 21 trial
Suzhou Junde Biotechnology Co., Ltd · Head and Neck Squamous Cell Carcinoma
- TL118Phase 21 trial
Teligene US · Solid Tumor
- TL938Phase 21 trial
Teligene US · Colorectal Cancer Metastatic, Advanced Colorectal Cancer
- TNG260Phase 21 trial
Tango Therapeutics, Inc. · Non Small Cell Lung Cancer, Solid Tumors, Adult, Lung Cancer
- TNG456Phase 21 trial
Tango Therapeutics, Inc. · Non Small Cell Lung Cancer, Glioma Glioblastoma Multiforme, Glioma, Malignant
- TominersenRO7234292, RG6042Phase 21 trial
Roche (Genentech) · Huntington Disease
- TPX-100Phase 21 trial
OrthoTrophix, Inc · Osteoarthritis (OA) of the Knee
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.